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Abstract
Human brain organoids, generated from pluripotent stem cells, have
emerged as a promising technique for modeling early stages of human
neurodevelopment in controlled laboratory conditions. Although the
applications for disease modeling in a dish have become routine, the use of
these brain organoids as evolutionary tools is only now getting momentum.
Here, we will review the current state of the art on the use of brain
organoids from different species and the molecular and cellular insights
generated from these studies. Besides, we will discuss how this model
might be beneficial for human health and the limitations and future
perspectives of this technology.
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Introduction
What is it that makes us uniquely human? Among several fea-
tures of our species, perhaps the most impactful characteris-
tic consists of our sophisticated brains and all the abilities and 
advanced lifestyles we all enjoy. However, a complex brain came 
with a cost. The vulnerability for human-specific neurological 
disorders might well be an undesired evolutionary trade-off. 
Although many genetic mutations might also cause diseases 
in other animals, the genomic landscape of humans makes our 
species more susceptible to certain neurological disorders1,2. 
Gaining a clearer understanding of human brain evolution is 
crucial to interpreting how human genetic variants lead to disease. 
Therefore, understanding the evolutionary path of the modern 
human brain will likely illuminate the origins of conditions such 
as autism, dementia, or schizophrenia, which are considerable 
burdens to all present and future human societies.
Our knowledge of human brain development is deficient and 
there are gaps in the critical steps leading to the cellular organi-
zation and the formation of functional networks that are the basis 
of cognition. The limited accessibility of the human (and also 
non-human primate, or NHP) brain has blocked our understand-
ing of neurodevelopment, especially at very early stages. During 
embryogenesis, a limited number of pluripotent embryonic 
stem cells will give rise to a multi-cellular and complex nervous 
system in the brain, which orchestrates many of the autono-
mous and non-autonomous functions of the body. In utero 
experimental access to ape brains is not always possible. Instead, 
scientists have relied on less invasive passive alternatives, 
such as ultrasound and functional imaging. Most of our under-
standing of normal and pathological brain conditions comes 
from postmortem tissues that represent only a blurry snapshot 
of a highly dynamic tissue. Also, the neuroanatomical and func-
tional heterogeneity that individuals have because of their 
genetic and environmental backgrounds adds another obstacle 
to fully understanding the typical and unhealthy progression 
of neurodevelopment3.
Brain organoids, generated from pluripotent stem cells, are 
multi-cellular, three-dimensional self-assemble miniaturized 
structures that mimic the dynamic organization4,5 and molecu-
lar profile of the developing human embryonic and fetal brain6–9. 
These structures can grow free floating in media or embedded 
in matrigel and develop different brain regions using endog-
enous patterning cues10,11. Alternatively, cells could be patterned 
early on by exposure to specific cocktails of factors, coaxing 
the identity of the cells toward a specific brain region4,12,13. Dif-
ferently patterned organoids independently created could be 
fused, exchanging signals among the different brain regions, 
stimulating cell exchange14–16 or reciprocal projections12,17. The 
“lego-organoid” approach can recreate specific circuit formations 
in a more controlled and reproducible fashion than non-patterned 
cerebral organoids.
Human brain organoid has recently contributed to the under-
standing of several neurological conditions (reviewed 
extensively in 18–20), including typically human conditions 
such as schizophrenia21 and autism22. Interestingly, the fact that 
brain organoids can be generated from induced pluripotent stem 
cells (iPSCs)23,24, reprogrammed from somatic cells of any spe-
cies, offered an unprecedented opportunity to compare early 
stages of human neurodevelopment with those of other primates, 
including our closest NHP relatives: the chimpanzees (Pan 
troglodytes) and bonobos (Pan paniscus)25–27. These three 
species have very similar genomes, including nearly 98% of 
alignable genomic sequence28. However, cellular and molecu-
lar phenotypes, especially at similar stages of development, 
are difficult to establish, mainly owing to limited access to live 
embryonic material from humans and NHPs. Thus, the study and 
manipulation of brain organoids in a dish are novel and promising 
evolutionary tools25.
LINEs might be responsible for human-specific 
diseases
The first comparative study between human and NHP iPSCs 
revealed unexpected differential regulation of long inter-
spersed element-1 (L1, also known as LINE-1) endogenous 
retrotransposons29. L1 elements are autonomous mobile elements 
present in around 20% of the mammalian genomes and have 
remained active during evolution30–33. Mobilization of L1s can 
impact the human genome and is associated with several human 
disorders34,35. Among the top 50 genes that were differentially 
expressed between human and NHP iPSCs, two L1-restricting 
factors—APOBEC3B (also known as A3B) and PIWIL2—were 
found upregulated in human cells. The experimental manipulation 
of A3B and PIWIL2 levels in the pluripotent stem cells 
supported a causal inverse relationship with L1 retrotransposi-
tion. Increased levels of L1 retrotransposition suggested that 
NHP-derived iPSCs would be more susceptible or permis-
sive to new insertions. An increased copy number of species- 
specific L1 elements in the genome of chimpanzees was 
observed when compared with humans. The data support the 
idea that increased L1 mobility in NHPs might not be limited 
to the pluripotent stage and may also occur in the germline dur-
ing primate evolution. Thus, it is possible to speculate that the 
activity of L1 elements has differentially shaped the human 
genome and still has adaptive significance.
The RNA from L1 elements might also have an impact on human 
health. Aicardi–Goutières syndrome (AGS) type I is character-
ized by a dramatic neuronal loss, leading to lifelong disability36. 
AGS can be caused by mutations in the three-prime repair exo-
nuclease I (TREX1) gene37. Curiously, rodent models of AGS 
do not mimic the severe neurological aspect of the human con-
dition38. However, AGS-derived brain organoids do mimic 
the neurodegeneration and striking microcephaly seen during 
patient neurodevelopment in utero39. Neuronal death in the 
brain organoids was caused, at least partially, by a substantial 
exposure of type I interferon, a pro-inflammatory cytokine 
secreted by astrocytes. The innate immune reaction in the astro-
cytes was triggered by the accumulation of L1 retrotransposons 
in the cell because of TREX1 absence. L1 elements are 
different between humans and other animals40. Evidence that L1 
activity could contribute to other neurological disorders, such 
as Huntington’s disease41, Down syndrome, and Alzheimer’s 
disease42, and aging43 has recently been provided. It is an attrac-
tive hypothesis that the sequence-specific L1 differences might 
contribute to several human conditions, creating the potential 
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for unconventional treatments using reverse transcriptase inhibi-
tors, such as anti-HIV drugs.
Emergent viruses and brain defects
Endogenous viruses are not the only ones affecting human evo-
lution. Human brain organoids played an essential role in the 
causal link demonstration between the Brazilian Zika virus and 
the microcephaly outbreak in Brazil. The relatively slow human 
neurodevelopment, compared with that of other experimen-
tal animal models mimicked by the human brain organoids in a 
dish, allowed investigators to dissect how the virus could infect 
neural progenitor cells leading to defects in the cortical plate44–46. 
Moreover, brain organoids from NHPs revealed differences 
in viral replication rates of the Brazilian strain compared with 
the African Zika virus at the same developmental stage. This 
observation might suggest that the Zika virus can adapt to 
different primates. Evidence for specific mutations in the 
circulating Brazilian Zika virus has emerged47 but it is unclear 
whether these variants were responsible for the dramatic 
phenotypes seen in the affected human babies. The abundance 
of human brain organoids was also a positive feature to rapidly 
screen for drugs that could prevent infection48,49 or block viral 
replication and eventual vertical transmission50.
Exploring cortical development
In the past, testing hypotheses about human brain evolution 
was restricted to manipulations in animals or non-relevant cell 
types. Owing to cellular reprogramming, it is now possible to 
compare differences and similarities between human neurode-
velopment and that of other primates without the use of embry-
onic materials that are ethically and technically difficult to 
access29,51. The ability to create cortical brain organoids from 
human and other NHP iPSCs provides a unique opportunity to 
study the expansion of the neocortex in a dish26,52. By contrasting 
brain organoids of humans with those of chimpanzees, it was 
possible to determine a subtle differentiation between timing and 
lengthening of prometaphase-metaphase in human apical mito-
sis that is specific to proliferating neural progenitor cells27,53,54. 
It is possible that subtle differences at very early stages have a 
more dramatic impact later in development and thus set humans 
apart from other primates.
Cortical tissues generated from human, chimpanzee, orangu-
tan, and rhesus iPSC-derived brain organoids were also used 
for a dynamic transcriptional analysis55. Several long non- 
coding RNAs (lncRNAs) were detected in specific cell types 
and stages of differentiation in all of the species. LncRNAs 
are implicated in several molecular mechanisms, including the 
regulation of neurodevelopment56,57. The conservation of pattern 
expression on these tissue-specific lncRNAs in all of these 
primates indicates a possible role in transition stages during 
neurodevelopment. Another recent work that contrasted brain 
organoids from human and NHP iPSCs also described gene 
network conservation among primates while identifying a set 
of 261 genes that are human-specific58. Some of these genes 
overlap with recent chromosomal segmental duplications59. 
Interestingly, increased activation of the PI3K/AKT/mTOR 
pathway was validated in the radial glia cells of the outer 
subventricular zone of human fetal brain tissues, possibly 
contributing to the neocortex expansion during evolution. The 
creation of a “brain organoid zoo”, which has representatives of 
different primates and other species, might help us to resolve 
critical molecular and cellular steps to comprehend brain 
evolution better.
Discussion and future perspectives
Our natural interest in understanding the processes that make 
us human goes beyond mere anthropocentrism and philosophi-
cal debates about the human condition. Novel knowledge gained 
from interspecies comparisons can potentially contribute to bio-
medical advances. For example, humans and other primates 
can be distinguished by AIDS progression60, malaria vulner-
ability (immunity against Plasmodium falciparum)61, Alzheimer’s 
disease (absence of neurofibrillary tangles)62, and susceptibil-
ity to certain cancers63 as well as other differences64,65. The iden-
tification and characterization of the cellular and molecular 
mechanism that distinguishes humans from our closest relatives 
at early stages of embryogenesis and in specific types of cells 
are likely to become a new resource for evolutionary studies66. 
In this context, recent advances in iPSC-derived neural pro-
genitor cells and brain organoids are an attractive tool to dissect 
cellular and molecular events that contribute to the uniqueness 
of the human brain. However, this artificial in vitro approach 
is not without serious inherent limitations. Most comparative 
studies are standardizing the growth of the brain organoids 
using human culture conditions. This “humanized” situation 
is likely masking important differences among species. The 
use of “neutral backgrounds”, such as transplanting different 
primate cells in the mouse brain54, could mitigate this concern. 
Other limitations are intrinsic to the brain organoid model: lack 
of specific cell types, cellular stress, organized brain regions, and 
endogenous vascularization. The use of patterned brain organoids 
might help to reduce experimental variability and increase 
confidence in the data, especially when differences are subtle. 
Thus, owing to these limitations, validation or confirmation of 
findings in primary tissues58,67 or even intact functional brain68 
is the gold standard in this field.
Nonetheless, it is expected that some of these technical shortcom-
ings might be resolved in the next few years (reviewed in 18,69). 
In the future, evolutionary studies using brain organoids would 
benefit from genome editing for candidate approaches. More 
sophisticated comparisons will also incorporate functional 
readouts, such as the emergence of network activity and 
oscillatory waves in long-term, mature brain organoids68. Finally, 
the perspective to extrapolate the comparative approach of mod-
ern humans to other extinct hominins, such as Neanderthals 
and Denisovans, by using human brain organoids carrying 
ancestral genetic variants will lead to an entire new field70.
Abbreviations
AGS, Aicardi–Goutières syndrome; iPSC, induced pluripotent 
stem cell; L1 or LINE-1, long interspersed element-1; lncRNA, 
long non-coding RNA; NHP, non-human primate; TREX1, 
three-prime repair exonuclease I
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